Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Mar;20(1):99-105.
doi: 10.26574/maedica.2025.20.1.99.

Vitamin K-Dependent Inhibition Mechanisms in Human Aortic Valve Calcification

Affiliations
Review

Vitamin K-Dependent Inhibition Mechanisms in Human Aortic Valve Calcification

Symeon-Evangelos Mavroudeas et al. Maedica (Bucur). 2025 Mar.

Abstract

Introduction: Stenosis of the aortic valve is a leading cause of severe cardiovascular lesions. Progressive calcification, rheumatic modifications and also congenital events are the main etiopathogenetic factors. Extended fibrotic changes and aberrant ectopic calcification of the specific aortic valve interstitial cells are the most recognizable histopathological features. In fact, the previously referred cells are transformed from their initial myofibroblast phenotype to an osteoblast-like cell formation mediated by an inflammatory process. Concerning the potentially effective anti-calcification, inhibition strategies, some molecules are under investigation. Among them, vitamins seem to be involved in this process by preventing aortic wall extensive calcification. Objective: The purpose of the current review was to explore the involvement of Vitamin K complex in the inhibition mechanisms of the human aortic valve calcification process. Material and method: A systematic retrospective review of the literature was carried out based on PubMed international medical database. The following keywords were used: vitamin, calcification, cardiovascular, stenosis, aorta. Results: A broad spectrum of seventy (n=70) significant articles - focused on the vitamin K complex structural and functional aspects and its implication in anti-calcification mechanisms - were selected for the current review study. The majority of medical data referred to after 2015 published articles, whereas specific references of great importance and value were also included. Conclusions: Specific vitamin K members play a crucial role by regulating the activity of proteins such as osteocalcin that induces endothelial calcification. Interestingly, vitamin K also modifies the function of the matrix-Gla proteins that are implicated in this process. In fact, vitamin K-related molecular and biochemical mechanisms in the human aortic valve calcification inhibition are crucial and represent an interesting field for research.

PubMed Disclaimer

Conflict of interest statement

None declared.

Figures

FIGURE 1.
FIGURE 1.
Stereo-chemical structure of Vit K isoforms: K1 (phylloquinone), K2 (menaquinone) and K3 (menadione). 2-methyl-1,4-naphthoquinones central ring is the core Vit K1 represents a phylloquinone characterized by a group of four isoprenoid residues. One of them only is unsaturated. In contrast, Vit K2 is chemically a menaquinone with differences in the corresponding unsaturated isoprenoid residues. Vit K3 is a menadione, a synthetic Vit K variant, which interacts with glutathione. Two enzymes are implicated in the intracellular procedure (electron reduction and oxidization) that transforms Vit K to its active form (Vit K hydroquinone): Vitamin K epoxide reductase (VKER) and gamma-glutamyl carboxylase (Vit K-dependent carboxylase) . In fact, these two enzymes regulate the Vit K biochemical cycle that includes the carboxylation and epoxidation chemical reactions.

References

    1. Prabhakar AP, Lopez-Candales A. Calcific aortic valve disease and cardiometabolic triggers: an explanation behind progression of aortic valvular disease and failure of medical therapy interventions. Postgrad Med . 2024;23:1–9. - PubMed
    1. Nordestgaard BG, Langsted A. Lipoprotein(a) and cardiovascular disease. Lancet . 2024;404:1255–1264. - PubMed
    1. Chen S, Pop A, Prasad Dasi L, George I. Lifetime Management for Aortic Stenosis: Strategy and Decision Making in the Current Era. Ann Thorac Surg . 2025;119:296–307. - PubMed
    1. Coffey S, Roberts-Thomson R, Brown A, et al. Global epidemiology of valvular heart disease. Nat Rev Cardiol . 2021;18:853–864. - PubMed
    1. Rosenhek R, Klaar U, Schemper M, et al. Mild and moderate aortic stenosis. Natural history and risk stratification by echocardiography. Eur Heart . 2004;25:199–205. - PubMed

LinkOut - more resources